Advanced Prostate Cancer Series: PSMA-Targeted Therapies

Patients with advanced prostate cancer have many treatment options, but more alternatives are urgently needed. PSMA (Prostate Specific Membrane Antigen) is a molecule that sits on the surface of prostate cancer cells and is used as a target for treatment. Host Dr. Oliver Sartor (Mayo Clinic) speaks with Dr. Louise Emmett (University of New South Wales) and Dr. Michael Morris (Memorial Sloan Kettering Cancer Center). Learn about the current state of PSMA-targeted therapies as well as what’s on the horizon.

View Advanced Prostate Cancer Series: PSMA-Targeted Therapies transcript.